Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
This study aimed to examine the potential drug-drug interaction (DDI) between vandetanib and luteolin in vivo and in vitro, with the objective of establishing a scientific foundation for their appropriate utilization in clinical settings. Sprague-Dawley (SD) rats were randomly divided into two group...
Saved in:
| Main Authors: | Yuxin Shen, Fengsheng Hong, Hualu Wu, Xiaohai Chen, Hailun Xia, Ren-ai Xu, Guanyang Lin, Lu Shi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1526159/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a UPLC-MS/MS method for the determination of sulfatinib and its no interaction with myricetin in rats
by: Dongxin Chen, et al.
Published: (2024-12-01) -
Inhibitory effect of carvedilol on bedaquiline metabolism in vitro and in vivo
by: Qingqing Li, et al.
Published: (2025-04-01) -
Measurement of tepotinib by UPLC‒MS/MS and its interaction with naringenin in rats
by: Zhe Chen, et al.
Published: (2024-11-01) -
Development and validation of a UPLC-MS/MS method for the quantification of parsaclisib and its application to pharmacokinetics and metabolic stability studies
by: Chenjian Zhou, et al.
Published: (2025-07-01) -
Simultaneous Determination of Multiple Acid-Suppressing Drugs by UPLC-MS/MS Method and Application for Pharmacokinetics Study
by: Li X, et al.
Published: (2025-02-01)